Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20 
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Chinese Cars in Europe: Consumer Trust Is Shifting Fast 
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions 
SAN DIEGO, Oct. 09, 2017 -- Bionano Genomics, the structural variation company, announces a series of presentations at the upcoming American Society of Human Genetics (ASHG) Annual Meeting, October 17 to 21 in Orlando, Florida. Bionano will present Saphyr™, its most advanced system for genome mapping. Saphyr has roughly 10 times the throughput of its predecessor, allowing the system to generate sufficient data in one day to map up to two human genomes. This increase in throughput enables larger scale studies like the ones presented at this conference.
Erik Holmlin, Ph.D., CEO of Bionano, commented, “The last year saw a significant increase in the uptake of Bionano mapping in human genetic disease and cancer research. Scientists are understanding the importance of structural variation and realizing the inherent limitations of sequencing to find these large variants. We are thrilled to see Saphyr enabling the adoption of our technology for translational studies across populations and to see that Bionano mapping was able to identify disease causing variants for patients with genetic diseases for whom whole genome sequence wasn’t able to do so.”
Bionano will be hosting an Exhibitor Event led by prominent genomics researchers, Dr. Jim Broach from Penn State University, Dr. Vanessa Hayes from the Garvan Institute, and Dr. Hayk Barseghyan from Children’s National Medical Center. The discovery of structural variations using Bionano mapping in cancer and other genetic diseases will be presented.
Bionano will be onsite at Booth #555 to further discuss Bionano mapping, Saphyr, and findings presented during the various sessions.
Over a dozen different scientists are presenting Bionano data including:
Bionano Workshop:
| Solved with Bionano: How Order and Orientation Help Understand Genetic Disease. | |
| Presenting Authors: | Jim Broach, Vanessa Hayes and Hayk Barseghyan |
| Date, Time: | Friday, October 20, 1:00 pm – 2:15 pm |
| Location: | Hilton Orlando, Lake Mizell, Lobby Level |
Oral Presentations:
| Oral Session 80: Next-Generation Mapping (NGM): A novel approach for genetic diagnosis of structural variants. | |
| Presenting Author: | Hayk Barseghyan |
| Session: | #18: Strategies for Variant Interpretation |
| Date, Time: | Wednesday, October 18, 1:45 am – 12:00 pm |
| Location: | Room 230G – Level 2/Convention Center |
| Oral Session 26: Single-molecule mapping of complex genomic regions across 26 human populations reveals population specific variation patterns. | |
| Presenting Author: | Pui-Yan Kwok |
| Session: | #9: Genome Structure and Function: The Contribution of M |
| Date, Time: | Wednesday, October 18, 9:45 am – 10 am |
| Location: | Room 230G - Level 2/Convention Center |
Poster Presentations:
| Poster #808/W: Optical mapping reveals a higher level of chained fusion events in human cancer. | |
| Presenting Author: | Vanessa Hayes, Ph.D., Lab Head of Human Comparative and Prostate Cancer Genomics, Garvan Institute of Medical Research |
| Session: | Cancer Genetics |
| Date/Time: | Wednesday, October 18, 3 pm – 4 pm |
| Poster #1032/F: Combining Bionano and exome sequencing identifies a homozygous structural variation in the novel AGBL3 gene underlying microcephaly. | |
| Presenting Author: | Denice Belandres |
| Session: | Mendelian Phenotypes |
| Date/Time: | Friday, October 20, 12:30 pm – 1:30 pm |
| Poster #946/W: Characterization of a complex translocation causing 3q28ter duplication and 10q26.2ter deletion in a child with self-injurious behavior. | |
| Presenting Author: | Ikeoluwa Adeshina |
| Session: | Mendelian Phenotypes |
| Date/Time: | Wednesday, October 18, 3 pm – 4 pm. |
| Poster #1332/F: An alignment-based approach for sensitively detecting SVs using optical maps data. | |
| Presenting Author: | Xian Fan |
| Session: | Bioinformatics and Computational Approaches |
| Date/Time: | Friday, October 20, 12:30 pm – 1:30 pm |
| Poster #1487/T: Disease Relevant Structural Variation Analysis by Bionano Mapping. | |
| Presenting Author: | Alex Hastie |
| Session: | Omics Technologies |
| Date/Time: | Thursday, October 19, 2:00 pm – 3:00 pm |
| Poster # 1520/T: Automation of Ultra-High Molecular Weight DNA Isolation and Labeling for Genome Mapping. | |
| Presenting Author: | Pat Lynch |
| Session: | Omics Technologies |
| Date/Time: | Thursday, October 19, 3:00 pm – 4:00 pm |
| Poster #2582/T: Structural variant detection with optical mapping and microfluidic partitioning: A t(9;13) case report. | |
| Presenting Author: | Dustin Baldridge |
| Session: | Molecular and Cytogenetic Diagnostics |
| Date/Time: | Thursday, October 19, 3:00 pm – 4:00 pm |
| Poster # 788/T: Use of Bionano Genome Maps to Identify Medically-Relevant Genomic Variation. | |
| Presenting Author: | Andy Pang |
| Session: | Cancer Genetics |
| Date/Time: | Thursday, October 19, 3:00 pm – 4:00 pm |
More information about Bionano Genomics is available at www.bionanogenomics.com and in our newly released blog Bionano U at www.bionanogenomics.com/bionano-university/.
About Bionano Genomics
Bionano Genomics, Inc. provides the Irys® and Saphyr™ systems for Bionano Genome Mapping, which is the leading solution in physical genome mapping. Bionano mapping offers customers whole genome analysis tools that reveal true genome structure and enable researchers to capture what’s missing in their data to advance human, plant and animal genomic research. Bionano genome mapping uses NanoChannel arrays to image DNA at the single-molecule level with average single-molecule lengths of about 350,000 base pairs, which leads the genomics industry. The long-range genomic information obtained with Bionano mapping detects and deciphers structural variations (SVs), which are large, complex DNA segments involving repeats that are often missed by sequencing technologies and which are a leading cause of inaccurate and incomplete genome assembly. As a stand-alone tool, Bionano mapping enables the accurate detection of SVs, many of which have been shown to be associated with human disease as well as complex traits in plants and animals. As a complementary tool to next-generation sequencing (NGS), Bionano mapping integrates with sequence assemblies to create contiguous hybrid scaffolds for reference-quality genome assemblies that reveal the highly informative native structure of the chromosome. Bionano mapping also provides the additional ability to verify, correct and improve a NGS-generated genome assembly.
Only Bionano provides long-range genomic information with the cost-efficiency and high throughput to keep up with advances in NGS.
Bionano mapping has been adopted by a growing number of leading institutions around the world, including: National Cancer Institute (NCI), National Institutes of Health (NIH), Wellcome Trust Sanger Institute, BGI, Garvan Institute, Salk Institute, Mount Sinai and Washington University. Investors in the Company include Domain Associates, Legend Capital, Novartis Venture Fund and Monashee Investment Management.
For more information, please visit www.BionanoGenomics.com. Notes: Bionano Genomics is a trademark of Bionano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.
Bionano Genomics Media Contact
The Ruth Group
Kirsten Thomas
[email protected]
(508)280-6592
